logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
30/01/2026
According to a report released by Guojin Securities on January 30th, the company has given Keda Manufacturing (600499.SH) a "buy" rating. The main reasons for the rating include: 1) Increasing the net profit of the listed company's parent company, introducing high-quality shareholders, and deeply binding the interests of the listed company; 2) Expanding glass production capacity in Ghana. (Daily Economic News)
Latest
3 m ago
Kunlun WW: The net profit is expected to be negative in 2025.
4 m ago
Zhonghe Technology: Successfully secured the 432 million yuan bid for the procurement project of the signal system for the S2 line of Taizhou Urban Rail in China.
4 m ago
This steel plate company: net loss of 3.83 billion yuan in 2025, a year-on-year decrease in loss of 23.97%
4 m ago
Rongchang Biology stated on the interactive platform that the rise in Vor's stock price is beneficial for the company in two aspects. On one hand, it helps broaden its financing channels and strengthen its capital reserves to provide financial support for the smooth progress of the overseas global multicenter Phase III clinical trial of Taivosip. On the other hand, the increase in Vor's stock price, of which the company holds subscription warrants, will also increase the potential investment returns for the company.
5 m ago
Pintan Development: it is estimated that the net profit will be a loss of 65-130 million yuan by 2025.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.